Ho Young Kang Selected Research

3-(3,4-dihydroxy-phenyl)-acrylic acid 2,2- dimethyl- 8- oxo- 3,4- dihydro- 2H,8H- pyrano(3,2- g)chromen- 3- yl- ester

1/2019

CGK062, a small chemical molecule, inhibits cancer upregulated gene 2‑induced oncogenesis through NEK2 and β‑catenin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ho Young Kang Research Topics

Disease

3	Neoplasms (Cancer) 12/2022 - 05/2015
3	Infections 02/2022 - 04/2002
1	Skin Diseases (Skin Disease) 05/2019
1	Inflammation (Inflammations) 05/2019
1	Carcinogenesis 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Hypoxia (Hypoxemia) 05/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2015
1	Virus Diseases (Viral Diseases) 05/2015
1	Ischemia 02/2012
1	Cerebral Infarction 02/2012
1	Ischemic Stroke 02/2012
1	Parkinson Disease (Parkinson's Disease) 04/2007

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 12/2022 - 05/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022
1	VaccinesIBA 02/2022
1	MagnesiumIBA 05/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	3-(3,4-dihydroxy-phenyl)-acrylic acid 2,2- dimethyl- 8- oxo- 3,4- dihydro- 2H,8H- pyrano(3,2- g)chromen- 3- yl- esterIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 05/2015
1	Small Interfering RNA (siRNA)IBA 05/2015
1	ChemokinesIBA 02/2012
1	CXCR4 Receptors (CXCR4 Receptor)IBA 02/2012
1	Levodopa (L Dopa)FDA LinkGeneric 04/2007
1	Dopamine (Intropin)FDA LinkGeneric 04/2007
1	Dopamine Agonists (Dopamine Agonist)IBA 04/2007
1	Immunoglobulin G (IgG)IBA 04/2002

Therapy/Procedure

2	Therapeutics 02/2012 - 04/2007
1	Aftercare (After-Treatment) 05/2015
1	Drug Therapy (Chemotherapy) 05/2015
1	Radiotherapy 05/2015
1	Mesenchymal Stem Cell Transplantation 02/2012